Clinical usefulness of measuring the number of Circulating Tumor Cells (CTC) in breast cancer patients
Journal Title: OncoReview - Year 2013, Vol 3, Issue 3
Abstract
Background: Monitoring the breast cancer patients after an adjuvant therapy usually involves imaging methods or biopsy. Alternatively, breast cancer markers can be determined – one of them is the number of circulating tumor cells (CTC).Aim: The aim of this study was to compare the efficacy of standard monitoring methods and those based on CTC count.Materials and methods: Systematic review of PubMed database was performed. Inclusion criteria were met by 16 clinical trials, 9 reviews and 5 treatment recommendations.Results: CTC assay sensitivity was between 39% and 55% compared to the imaging, and 64% in combination with CA 27.29 (cancer antigen 27.29) marker. CTC specificity for the detection level of < 5 or ≥ 5 CTCs in blood was almost 100%. CTC assay enables correct classification of patients according to the neoplastic disease progression. Overall survival (OS) and progression free survival (PFS) were correlated with blood CTCs in metastatic patients. The study results suggest a link between CTC level and imaging diagnosis. Patients with CTC ≥ 5 were at a higher risk of disease progression, as diagnosed by radiographic methods, than patients with CTC < 5.Conclusions: Blood CTC measurement is a good clinical predictor of overall survival and progression-free survival and can be used for treatment efficacy monitoring in patients at high risk of recurrence or progression during advanced breast cancer treatment.
Authors and Affiliations
Dariusz Brenski
Keywords
Related Articles
- EP ID EP67724
- DOI -
- Views 223
- Downloads 0
Zastosowanie echokardiografii w onkologii – uwagi praktyczne
Artykuł przedstawia współczesne zastosowanie echokardiografii w wykrywaniu pierwotnych i przerzutowych nowotworów serca oraz w ocenie ryzyka sercowo-naczyniowego związanego z farmakologicznym i zabiegowym leczeniem nowot...
Toxicity profile of lapatinib plus capecitabine in advanced breast cancer – a single-centre follow-up study
Breast cancer is the most prevalent female neoplasm in Poland as well as in the rest of the world, accounting for 25% of all cancers. Lapatinib is a reversible inhibitor of the HE -1 and HER-2 tyrosine kinase receptors....
The role of granulocyte colony-stimulating factors in the prevention of neutropenia and febrile neutropenia – the current state of knowledge
Granulocyte colony-stimulating factors, introduced in the 1990s to prevent neutropenic fever, improve patients’ prognosis after myelotoxic chemotherapy. G-CSFs accelerate bone marrow recovery, shortening the duration of...
New data concerning treatment of urogenital cancer patients presented at annual congress of American Society of Clinical Oncology 2011
INTRODUCTION: The annual congress of The American Society of Clinical Oncology took place between 03.06.2011 and 06.06.2011 in Chicago, the US.MATERIAL AND METHODS: Papers presented during ASCO are discussed in four sect...
Zespół rozpadu guza
Zespół rozpadu guza jest stanem zagrożenia życia występującym u pacjentów z rozległymi nowotworami, u których pod wpływem chemioterapii bądź samoistnie dochodzi do masywnego rozpadu komórek nowotworowych z uwolnieniem ic...